Dongwha Pharm.Co.,Ltd (KRX:000020)

Dongwha Pharm.Co.,Ltd Revenue

Dongwha Pharm.Co.,Ltd had revenue of 130.61B KRW in the quarter ending March 31, 2026, with 3.93% growth. This brings the company's revenue in the last twelve months to 501.33B, up 6.29% year-over-year. In the year 2025, Dongwha Pharm.Co.,Ltd had annual revenue of 496.39B with 6.78% growth.

• Revenue (ttm): 501.33B
• Revenue Growth: +6.29%
• P/S Ratio: 0.30
• Revenue / Employee: 606.94M
• Employees: 827
• Market Cap: 151.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	496.39B	31.52B	6.78%
Dec 31, 2024	464.87B	103.77B	28.74%
Dec 31, 2023	361.11B	20.68B	6.08%
Dec 31, 2022	340.43B	47.41B	16.18%
Dec 31, 2021	293.02B	20.94B	7.70%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error